跳至主要内容
临床试验/ITMCTR2000004159
ITMCTR2000004159招募中4 期

A multi-center real-world clinical research program for the application of Motherwort injection in the field of family planning after the market

He'nan Provincial People's Hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
18 至 40(—)
性别
Female

入选标准

  • 1. After induced abortion
  • Women of childbearing age who were diagnosed with pregnancy and required abortion were selected as the subjects of the study. And meet the following criteria:
  • 1) Women eligible for induced abortion;
  • 2) Aged18-40 years old, in good health in the past;
  • 3) Can fill in the bleeding card;
  • 4) Volunteer for the study.
  • (2) After placing the IUD
  • Women of childbearing age who were selected for IUD placement were studied. And meet the following criteria:
  • 1) If the IUD is selected and placed as a long-term contraceptive method, or vaginal bleeding >=8 days after the PLACEMENT of the IUD;
  • 2) Can fill in the bleeding card;
  • 3) Volunteer to participate in the study and sign the informed consent.
  • (3) After the IUD is removed
  • Healthy women who had their IUDs removed were selected and studied for reasons such as pregnancy or menopause. And meet the following criteria:
  • 1) Patients aged between 20 and 65 who voluntarily take the ring without surgical contraindications;
  • 2) Can fill in the bleeding card;
  • 3) Volunteer to participate in the study and sign the informed consent.

排除标准

  • 1) Allergy to this product or excipients listed in motherwort preparation and ingredients or history of serious adverse reactions;
  • 2) Patients with allergic constitution (allergic to motherwort or to motherwort preparation) + pregnant women;
  • 3) Patients whom the researcher considers inappropriate.

研究者

发起方
He'nan Provincial People's Hospital

相似试验

已完成
不适用
CLINICAL RESEARCH PROJECT ON A MULTI-CENTRE RANDOMIZED DOUBLE-BLIND PLACEBO CONTROLLED IN PARALLEL GROUPS STUDY TO EVALUATE THE EFFECTIVENESS SAFETY AND TOLERABILITY OF TIORFAN 1.5 MG / KG BODY WEIGHT ADMINISTERED 3 TIMES PER DAY ORALLY JOINTLY WITH ORAL REHYDRATION TREATMENT VERSUS PLACEBO IN CONJUNCTION WITH ORAL TREATMENT OF REHYDRATION IN THE TREATMENT OF ACUTE DIARRHEA IN CHILDREN.-K591 Functional diarrhoeaFunctional diarrhoeaK591
PER-031-99SMITHKLINE BEECHAM INTERAMERICAN,
招募中
Unknown
A multicenter, patient-control exploratory clinical trial for the clinical efficacy and safety assessment of a virtual reality-based cognitive assessment software (VARABOM-Diagnosis), aimed at assisting the mild cognitive impairment (MCI) screening diagnosis through cognitive function evaluation in patients with MCI.Mental and behavioural disorders
KCT0009132Yonsei University Health System, Gangnam Severance Hospital84
尚未招募
2 期
Efficacy of tREating aSymptomatic infEctions To resTore fERtility: The RESETTER StudyReproductive Health and Childbirth - Fertility including in vitro fertilisationInfertility
ACTRN12624001180505University of Western Australia440
已完成
不适用
A multicenter study to examine clinical scenarios for long-term monitoring of epileptic seizures with a wearable biopotential technologyG40.2Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
DRKS00025547Department of Neurology, UZ Leuven495
招募中
不适用
Multicenter and Prospective Clinical Study for the Development of Multi-Omics-Based Biomarkers in Acute Myeloid LeukemiaDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanism
KCT0004825Chonnam National University Hospital Hwasun Hospital620